Cannabis Science Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, has announced that its initial product analyzing and production run has been completed and the commercial packaging process is now underway.
This will be the first set of Cannabis Science brand formulations being released, scheduled for later this month through its producing lab and initial Colorado State licensed dispensary. The company's CEO, Dr. Robert Melamede, has chosen specially selected medical marijuana dispensaries in Colorado that will offer the Cannabis Science formulations to patients in accordance with Colorado State laws and regulations.
Dr. Robert Melamede, Ph.D., the company's CEO, says, "We hear from so many people wanting a reliable, high-quality formulation that they can self-administer to treat a wide variety ailments. A quality, standardized formulation is essential for long term care. As far as I know, we have the only formulation made from organically grown cannabis bud, and produced in a professional, Colorado State licensed, laboratory facility. Initially, we have chosen two facilities in Colorado to work with, both of the facilities were chosen for the quality of their botanicals and patient care. We are looking forward to expanding availability to other legal medical marijuana facilities and States along with an increased multiple formulation offerings."
Source: Cannabis Science Inc.